Latest Tech News

Stay updated with the latest in technology, AI, cybersecurity, and more

Filtered by: compound Clear Filter

Novo Nordisk Abruptly Ends Partnership with Hims, Claiming ‘Sham Compounding’ GLP-1 Drugs

gizmodo.com Ed Cara 2025-09-02 10:04:21

Bad blood is brewing among some major players in the weight loss world. Novo Nordisk, the creator of Ozempic and Wegovy, cut short its partnership with telehealth company Hims & Hers Health Inc. over allegations that the latter is still trying to mass-market cheaper versions of the GLP-1 drugs. Bloomberg News reported the abrupt dissolution of the partnership Monday, just two months after it was struck. Novo claims that Hims is using “deceptive marketing” to widely sell compounded semaglutide t

Topics: compounded drugs glp hims novo
Read More
Shop Amazon

Bioprospectors mine microbial genomes for antibiotic gold

news.ycombinator.com Max Barnhart 2025-09-11 02:46:34

In brief The discovery of penicillin nearly 100 years ago started a gold rush to find new antimicrobials. Scientists mined microscopic bacteria and fungi for compounds that could help fight off infection. But over time the rate of antimicrobial discoveries slowed to a crawl. Now, modern-day bioprospectors are using genomics, synthetic biology, and AI to dig deeper than they ever have before. A new golden age of antibiotics may be upon us, say some on the hunt, though getting a drug candidate int

Topics: antimicrobial antimicrobials compound compounds says
Read More
Shop Amazon

Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage

cnbc.com Ashley Capoot 2025-06-04 10:02:43

Shares of Hims & Hers Health closed down around 26% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved. Semaglutide is the active ingredient in Novo Nordisk's blockbuster weight loss drug Wegovy and diabetes treatment Ozempic. Those medications are part of a class of drugs called GLP-1s, and demand for the treatments has exploded in recent years. As a result, digital health companies such as Hims & Hers have been

Topics: compounded drugs hims medications semaglutide
Read More
Shop Amazon

Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage

cnbc.com Ashley Capoot 2025-06-04 12:56:39

Shares of Hims & Hers Health tumbled more than 23% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved. Semaglutide is the active ingredient in Novo Nordisk's blockbuster weight loss drugs Wegovy and diabetes treatment Ozempic. Those medications are part of a class of drugs called GLP-1s, and demand for the treatments has exploded in recent years. As a result, digital health companies like Hims & Hers have been pr

Topics: company compounded friday hims semaglutide
Read More
Shop Amazon
Trending Topics
Hot Now
ai 1495 apple 1095 new 903 content 844 google 676
Popular
like 654 zdnet 647 amazon 646 does 527 company 527 reviews 520 editorial 506 day 492 app 480 said 450
Emerging
data 447 prime 446 samsung 398 phone 394 game 385 pro 384 just 373 android 352 deals 338 galaxy 323
About GoKawiil

GoKawiil is a project by nerdhub.co that curates technology news from trusted sources. We built this site to provide a cleaner, more mobile-friendly experience without intrusive ads or heavy JavaScript.

Privacy

Your privacy matters. GoKawiil doesn't use Google Analytics or Facebook Pixel. The only tracking occurs through affiliate links to Amazon.

Advertising

Interested in advertising? Contact us at [email protected]